Sandoz Settles Drug Price-Fixing Case In U.S. Will Indian Pharma Firms Follow Suit?
An employee checks sealed packets of tablets as they move along the production line at a drug manufacturing unit (Photographer: Andrey Rudakov/Bloomberg)

Sandoz Settles Drug Price-Fixing Case In U.S. Will Indian Pharma Firms Follow Suit?

Novartis AG’s Sandoz became the first large generic drugmaker to reach a settlement with the U.S. Department of Justice in a price-fixing case. It has agreed to pay a penalty of $195 million to set...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.